Hypertensive crisis in cardiology: Place of urapidil

Kobalava Zh.D. ¹ , Kotovskaya Yu.V. ¹ , Bagmanova N.Kh. ¹ , Artyukhov O.P. ¹ , Darmaeva I.P. ¹

КАРДИОЛОГИЯ

KlinMed Consulting

1

Русский

86-90

Опубликовано

52

2012

• ¹ Russian University of Peoples Friendship, Vavilova st. 61, 117292 Moscow, Russian Federation

antihypertensive agent; piperazine derivative; urapidil; drug effect; drug monitoring; heart rate; hemodynamics; human; hypertension; intravenous drug administration; pathophysiology; randomized controlled trial (topic); review; risk factor; secondary prevention; Antihypertensive Agents; Drug Monitoring; Heart Rate; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Piperazines; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention

19.10.2018

09.02.2022

https://repository.rudn.ru/ru/records/article/record/2207/